BeiGene
BGNE
#963
Rank
HK$155.62 B
Marketcap
HK$1,371
Share price
1.02%
Change (1 day)
-0.84%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Stock price history for BeiGene (BGNE)

Highest end of day price: HK$3,132 HKD on 2021-09-17

Lowest end of day price: HK$186.32 HKD on 2016-02-12

Stock price history of BeiGene from 2016 to 2024

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
HK$7.73-0.47%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$11.97-1.91%๐Ÿ‡บ๐Ÿ‡ธ USA